Tilray (NASDAQ:TLRY) Shares Down 2.1%

Shares of Tilray Inc (NASDAQ:TLRY) traded down 2.1% on Tuesday . The stock traded as low as $1.65 and last traded at $1.67. 7,019,169 shares changed hands during trading, a decline of 72% from the average session volume of 25,255,430 shares. The stock had previously closed at $1.70.

Tilray Stock Up 1.2 %

The company has a market capitalization of $1.45 billion, a P/E ratio of -3.91 and a beta of 2.13. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The stock’s fifty day moving average is $1.82 and its 200 day moving average is $1.87.

Tilray (NASDAQ:TLRY) last released its earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter in the previous year, the business posted ($0.15) earnings per share. Tilray’s revenue for the quarter was up 24.8% on a year-over-year basis. Research analysts predict that Tilray Inc will post -0.12 EPS for the current fiscal year.

Institutional Trading of Tilray

Several institutional investors and hedge funds have recently modified their holdings of TLRY. Prospect Financial Services LLC purchased a new stake in shares of Tilray during the 2nd quarter valued at about $26,000. RPO LLC purchased a new position in Tilray during the fourth quarter valued at approximately $28,000. Simplicity Wealth LLC bought a new position in Tilray in the first quarter worth approximately $28,000. Gainplan LLC purchased a new position in Tilray in the fourth quarter valued at about $28,000. Finally, Wellington Wealth Strategies LLC. bought a new stake in shares of Tilray in the 4th quarter valued at about $29,000. 9.35% of the stock is currently owned by institutional investors.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.